Ultragenyx Pharma (RARE) Prices 4.44M Share Common Offering at $90/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- BioNTech ends colorectal cancer mRNA therapy trial early
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Needham sees mature node semiconductor strength in latest tracker
Ultragenyx Pharma (RARE) PT Raised to $116 at Cowen
October 28, 2020 6:59 AM EDTCowen analyst Yaron Werber raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $116.00 (from $90.00) while maintaining an Outperform rating.
The analyst commented, "RARE reported Q3:20 earnings with OpEx of $132M v our $128M estimates & steady growth in sales of Crysvita & Dojolvi.... More
Ultragenyx Pharma (RARE) PT Raised to $105 at Wedbush
October 28, 2020 6:28 AM EDTWedbush analyst Laura Chico raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $105.00 (from $97.00) while maintaining a Outperform rating.... More
Ultragenyx Pharma (RARE) PT Raised to $121 at Barclays
October 28, 2020 4:59 AM EDTBarclays raised its price target on Ultragenyx Pharma (NASDAQ: RARE) to $121.00 (from $99.00) while maintaining a Overweight rating.... More
Ultragenyx Pharma (RARE) Tops Q3 EPS by 14c, Revenues Beat
October 27, 2020 4:45 PM EDTUltragenyx Pharma (NASDAQ: RARE) reported Q3 EPS of ($1.13), $0.14 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $53.89 million.
Third quarter 2020 total revenue of $81.5 million and Crysvita revenue of $37.3 millionIncreased lower end of... More